Your browser doesn't support javascript.
loading
Prevalence, seroconversion and mother-to-child transmission of dual and triplex infections of HIV, hepatitis B and C viruses among pregnant women in Nigeria: study protocol.
Eleje, George Uchenna; Mbachu, Ikechukwu Innocent; Ogwaluonye, Uchenna Chukwunonso; Kalu, Stephen Okoroafor; Onubogu, Chinyere Ukamaka; Nweje, Sussan Ifeyinwa; Uzochukwu, Chinwe Elizabeth; Nwankwo, Chike Henry; Fiebai, Preye Owen; Loto, Olabisi Morebise; Akaba, Godwin Otuodichinma; Usman, Hadiza Abdullahi; Rabiu, Ayyuba; Egeonu, Richard Obinwanne; Igue, Odion Emmanuel; Adesoji, Bukola Abimbola; Jibuaku, Chiamaka Henrietta; Aja, Prince Ogbonnia; Chidozie, Chiamaka Perpetua; Ibrahim, Hadiza Sani; Aliyu, Fatima Ele; Numan, Aisha Ismaila; Okoro, Ogbonna Dennis; Omoruyi, Solace Amechi; Oppah, Ijeoma Chioma; Anyang, Ubong Inyang; Ahmed, Aishat; Chukwurah, Shirley Nneka; Umeononihu, Osita Samuel; Chukwuanukwu, Rebecca Chinyelu; Umeh, Eric Okechukwu; Emeka, Ekene Agatha; Ogbuagu, Chukwuanugo Nkemakonam; Yakasai, Ibrahim Adamu; Ezechi, Oliver Chukwujekwu; Ikechebelu, Joseph Ifeanyichukwu.
Affiliation
  • Eleje GU; Department of Obstetrics and Gynecology, Nnamdi Azikiwe University, Awka, Nigeria. georgel21@yahoo.com.
  • Mbachu II; Department of Obstetrics and Gynecology, Nnamdi Azikiwe University Teaching Hospital, PMB 5025, Nnewi, Anambra State, Nigeria. georgel21@yahoo.com.
  • Ogwaluonye UC; Department of Obstetrics and Gynecology, Nnamdi Azikiwe University, Awka, Nigeria.
  • Kalu SO; Department of Obstetrics and Gynecology, Nnamdi Azikiwe University Teaching Hospital, PMB 5025, Nnewi, Anambra State, Nigeria.
  • Onubogu CU; Department of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Nigeria.
  • Nweje SI; HIV Care Laboratory/HIV Care Department, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria.
  • Uzochukwu CE; Department of Paediatrics, Nnamdi Azikiwe University, Awka, Nigeria.
  • Nwankwo CH; Department of Nursing, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria.
  • Fiebai PO; Department of Mass Communication, Nnamdi Azikiwe University, Awka, Nigeria.
  • Loto OM; Department of Statistics, Nnamdi Azikiwe University, Awka, Nigeria.
  • Akaba GO; Department of Obstetrics and Gynecology, University of Port Harcourt, PortHarcourt, Nigeria.
  • Usman HA; Department of Obstetrics and Gynecology, University of Port Harcourt Teaching Hospital, PortHarcourt, Nigeria.
  • Rabiu A; Department of Obstetrics and Gynecology, Obafemi Awolowo University, Ile Ife, Nigeria.
  • Egeonu RO; Department of Obstetrics and Gynecology, Obafemi Awolowo University Teaching Hospital Complex, Ile-Ife, Nigeria.
  • Igue OE; Department of Obstetrics and Gynecology, University of Abuja, Abuja, Nigeria.
  • Adesoji BA; Department of Obstetrics and Gynecology, University of Abuja Teaching Hospital, Abuja, Nigeria.
  • Jibuaku CH; Department of Obstetrics and Gynecology, University of Maiduguri, Maiduguri, Nigeria.
  • Aja PO; Department of Obstetrics and Gynecology, University of Maiduguri Teaching Hospital, Maiduguri, Nigeria.
  • Chidozie CP; Department of Obstetrics and Gynecology, Bayero University, Kano, Nigeria.
  • Ibrahim HS; Department of Obstetrics and Gynecology, Aminu Kano Teaching Hospital, Kano, Nigeria.
  • Aliyu FE; Department of Obstetrics and Gynecology, Nnamdi Azikiwe University Teaching Hospital, PMB 5025, Nnewi, Anambra State, Nigeria.
  • Numan AI; Department of Physiological Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria.
  • Okoro OD; Department of Nursing, Obafemi Awolowo University Teaching Hospital Complex, Ile-Ife, Nigeria.
  • Omoruyi SA; Department of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Nigeria.
  • Oppah IC; Immunology Unit, Department of Medical Laboratory Science, Nnamdi Azikiwe University, Awka, Nigeria.
  • Anyang UI; Immunology Unit, Department of Medical Laboratory Science, Nnamdi Azikiwe University, Awka, Nigeria.
  • Ahmed A; Department of Obstetrics and Gynecology, Aminu Kano Teaching Hospital, Kano, Nigeria.
  • Chukwurah SN; Department of Obstetrics and Gynecology, Aminu Kano Teaching Hospital, Kano, Nigeria.
  • Umeononihu OS; Department of Obstetrics and Gynecology, University of Maiduguri Teaching Hospital, Maiduguri, Nigeria.
  • Chukwuanukwu RC; Department of Parasitology & Entomology, Faculty of Veterinary Medicine, University of Maiduguri Borno State, Maiduguri, Nigeria.
  • Umeh EO; Department of Obstetrics and Gynecology, University of Port Harcourt Teaching Hospital, PortHarcourt, Nigeria.
  • Emeka EA; Department of Obstetrics and Gynecology, University of Port Harcourt Teaching Hospital, PortHarcourt, Nigeria.
  • Ogbuagu CN; Department of Obstetrics and Gynecology, University of Abuja Teaching Hospital, Abuja, Nigeria.
  • Yakasai IA; Department of Obstetrics and Gynecology, University of Abuja Teaching Hospital, Abuja, Nigeria.
  • Ezechi OC; Department of Medicine, Faculty of Medicine, Nnamdi Azikiwe University, Awka, Nigeria.
  • Ikechebelu JI; Department of Obstetrics and Gynecology, Nnamdi Azikiwe University, Awka, Nigeria.
Reprod Health ; 17(1): 144, 2020 Sep 25.
Article in En | MEDLINE | ID: mdl-32977846
ABSTRACT

BACKGROUND:

Nigeria contributes significantly to the global burden of HIV, Hepatitis B and C infections, either singly or in combinations, despite progress in HIV care regionally and globally. Although some limited data on mono infection of HIV, Hepatitis B and C virus infections do exists, that of dual and triplex infections, including seroconversion and mother-to-child transmission (MTCT) rates necessary for planning to address the scourge of infections in pregnancy are not available.

OBJECTIVES:

To determine the seroprevalence, rate of new infections, MTCT of dual and triple infections of HIV, Hepatitis B and C viruses and associated factors, among pregnant women in Nigeria.

METHOD:

A multicenter prospective cohort study will be conducted in six tertiary health facilities randomly selected from the six geopolitical zones of Nigeria. All eligible pregnant women are to be tested at enrollment after informed consent for HIV, Hepatitis B and C virus infections. While those positive for at least two of the infections in any combination will be enrolled into the study and followed up to 6 weeks post-delivery, those negative for the three infections or positive for only one of the infections at enrolment will be retested at delivery using a rapid diagnostic test. On enrolment into the study relevant information, will be obtained, and laboratory test of CD4 count, liver function test and full blood counts, and prenatal ultrasonography will also be obtained/performed. Management of mother-newborns pairs will be according to appropriate national guidelines. All exposed newborns will be tested for HIV, HBV or HCV infection at birth and 6 weeks using PCR technique. The study data will be documented on the study case record forms. Data will be managed with SPSS for windows version 23. Ethical approval was obtained from National Health Research Ethics Committee (NHREC) (NHREC/01/01/2007-23/01/2020).

CONCLUSION:

Pregnant women with multiple of HIV, HBV and HCV infections are at increased risk of hepatotoxicity, maternal and perinatal morbidity and mortality. Additionally, infected pregnant women transmit the virus to their unborn baby even when asymptomatic. Children born with any of the infection have significantly poorer quality of life and lower five-year survival rate. Unfortunately, the seroconversion and MTCT rates of dual or triplex infections among pregnant women in Nigeria have not been studied making planning for prevention and subsequent elimination of the viruses difficult. The study is expected to fill this knowledge gaps. Nigeria joining the rest of the world to eliminate the triple infection among children rest on the availability of adequate and reliable data generated from appropriately designed, and powered study using representative population sample. The establishment of the three-in-one study of prevalence, rate of new infection, rate and risk factor for MTCT of dual and triple infection of HIV, Hepatitis B and C viruses among pregnant women in Nigeria is urgently needed for policy development and planning for the improvement of the quality of life of mothers and the elimination of childhood triplex infection.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Pregnancy Complications, Infectious / HIV Infections / Hepatitis C / Infectious Disease Transmission, Vertical / Seroconversion / Hepatitis B Type of study: Clinical_trials / Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Child / Female / Humans / Infant / Newborn / Pregnancy Country/Region as subject: Africa Language: En Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Pregnancy Complications, Infectious / HIV Infections / Hepatitis C / Infectious Disease Transmission, Vertical / Seroconversion / Hepatitis B Type of study: Clinical_trials / Guideline / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Child / Female / Humans / Infant / Newborn / Pregnancy Country/Region as subject: Africa Language: En Year: 2020 Type: Article